Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02689037Phase 3Unknown
Phase 3, randomised, open-label trial (2 arms), sponsored by 476th Hospital of the People's Liberation Army. Primary endpoint: Proportion of patients with events of stroke or death at 30 days. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02689037.